Stay updated with breaking news from Dig Howitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The $17 billion hearing implants maker has returned to profit, with its boss focused on emerging from the pandemic with a stronger market share. But the Delta variant could threaten its earnings forecast.
Shares in the hearing implant maker sank 7.5 pct after underlying net profit was lower than what the market was expecting.
Save Share Companies that patent medical and biotech research in Australia will pay half the corporate tax rate on earnings from those developments under measures to encourage innovation. The so-called âpatent boxâ will start on July 1, 2022, after consultation with industry, and could eventually be expanded to include the clean energy sector, Treasurer Josh Frydenberg said. The measure will reduce the corporate tax rate from 30 per cent to 17 per cent on profits derived from medical and biotech patents held in Australia. A âpatent boxâ has been a reform long-argued for by...
David Attenborough from Tabcorp. Their list of reforms included lower personal and corporate taxes funded by a higher GST, new tax incentives for investment in productive infrastructure, removal of state stamp duties, and payroll taxes. Advertisement Henry said the gap in corporate tax rates at the global level showed how Australia was out of step with competitors and risked missing out on mobile global capital. He said BHP’s Australian fiscal 2020 adjusted effective tax rate of 31.7 per cent (42.4 per cent including royalties) compared to an average of 21.49 per cent across the 36 nations ...